Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
41.26199
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
$25-$50k
0
71,995
42,603.4375
44,057
21.75
black
17
28
0.908936
0.875977
6
0
0
no
null
null
no dnr
25
45
19
125
14
39.09375
77
null
0.799927
0.899902
131
7.319336
346
18
2,912
null
0
no(M2 and SIP pres)
0
624
0
69.25397
male
0
23
MOSF w/Malig
ARF/MOSF
2
9
under $11k
9
85,837
48,802.375
52,449
19
white
28.5
47
0.438965
0.319946
13
1
0
yes
0.6
0.3
no dnr
23
71
6.299805
104
22
36.39844
null
1.099854
2.099609
1.899902
137
null
167
117
1,725
0
0
no(M2 and SIP pres)
0
105
1
20.767
female
1
121
MOSF w/Malig
ARF/MOSF
1
14
under $11k
0
314,505
null
null
16.25
white
25.898438
26
0.540894
0.426941
46
0
0
metastatic
0.7
0.5
dnr after sadm
121
83
12.5
76
16
36.29688
null
3.899902
0.699951
1.399902
135
null
68
23
null
5
4
no(M2 and SIP pres)
4
121
1
55.29398
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
61
25,610
14,894.8516
14,287
32
white
27.5
52
0.511963
0.395996
4
0
0
no
0.5
0.25
dnr after sadm
3
80
7.699219
110
12
36.79688
177.5
2.399902
null
0.799927
136
7.399414
141
11
2,430
null
null
<2 mo. follow-up
2.475586
5
1
32.62399
male
0
5
CHF
COPD/CHF/Cirrhosis
3
12
$11-$25k
0
9,490
5,901.4141
5,805
17
black
20
28
0.929932
0.880981
1
0
0
no
null
null
no dnr
5
70
5.399414
72
24
36.69531
459.25
null
0.5
1.299805
135
7.429688
62
24
850
0
0
null
0
622
0
62.5
male
1
5
Coma
Coma
0
3
under $11k
100
28,348
null
null
37
black
36.195313
71
0.018997
0.007999
1
0
0
no
0.1
0.5
dnr after sadm
4
113
6.299805
193
32
36.29688
118.35938
null
null
0.699951
135
7.399414
195
21
3,700
null
7
<2 mo. follow-up
7
5
1
44.52597
male
0
50
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
0
122,325
73,861.4375
75,465
24.75
black
31.097656
27
0.562988
0.450989
16
0
0
metastatic
0.3
0.2
no dnr
50
55
6.399414
67
20
36.5
null
null
0.799927
1
140
null
87
29
2,475
null
0
no(M2 and SIP pres)
0
165
1
52.82098
female
0
5
Colon Cancer
Cancer
2
12
$11-$25k
0
5,884
3,786.0137
3,873
13
white
20.699219
15
0.78894
0.554932
1
1
0
metastatic
0.9
0.95
no dnr
5
147
0.199982
135
30
35.79688
412
2.599609
11.898438
2.599609
142
7.399414
164
105
2,060
1
2
no(M2 and SIP pres)
2
153
1
42.41998
female
0
16
COPD
COPD/CHF/Cirrhosis
1
18
$25-$50k
0
21,687
14,074.9141
15,533
9.666664
black
20.597656
26
0.932983
0.885986
1
0
0
no
0.9
0.8
no dnr
16
113
18.597656
92
20
36.59375
242.84375
null
null
7
138
7.149414
200
67
null
0
null
no(M2 and SIP pres)
0.494751
621
0
65.36096
male
0
6
CHF
COPD/CHF/Cirrhosis
4
12
>$50k
0
10,511
6,464.8906
8,346
12
white
23.398438
30
0.820923
0.708984
1
1
0
no
0.9
0.85
no dnr
6
77
8.599609
60
36
38.19531
185.6875
2.899902
1.299805
2.199707
134
7.399414
356
70
1,200
1
3
no(M2 and SIP pres)
3
265
1
41.58197
male
0
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
36,979
null
null
20
white
29
44
0.784912
0.714966
4
0
0
no
0.95
0.95
no dnr
9
109
6.799805
95
16
36.39844
null
2.099609
0.299988
1.099854
137
null
97
17
null
null
null
null
2.427246
620
0
85.185
female
1
3
Coma
Coma
0
16
null
100
null
null
null
33
white
69.296875
58
0
0
1
0
0
no
null
null
dnr after sadm
1
53
14.298828
125
30
38.79688
130
null
null
1.399902
138
7.40918
106
27
2,730
null
null
<2 mo. follow-up
2.15918
3
1
72.20795
male
1
9
Coma
Coma
0
null
null
100
57,252
null
null
34
white
18.898438
31
0.209991
0.14798
5
0
0
no
null
null
dnr after sadm
3
68
null
65
16
35.79688
null
null
0.699951
1.399902
140
null
122
20
3,350
null
null
<2 mo. follow-up
2.241699
9
1
41.06998
female
1
4
Coma
Coma
2
null
null
100
45,291
null
null
22
white
40.898438
74
0.011
0.004
23
1
0
no
null
null
dnr after sadm
1
89.5
17.097656
115
24
36.5
228.96875
null
null
2.099609
148
7.399414
103
86
4,665
null
null
<2 mo. follow-up
2.875977
4
1
64.83197
male
1
9
MOSF w/Malig
ARF/MOSF
1
8
null
0
49,863
null
null
46.5
white
32.59375
57
0.350952
0.233978
3
0
0
metastatic
0.3
0.1
dnr after sadm
8
68
6.5
65
12
35.5
215
null
0.399963
0.699951
152
7.489258
222
10
1,190
null
6
<2 mo. follow-up
6
9
1
47.44397
female
0
20
COPD
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
24,405
15,665.9922
15,470
15
white
15.298828
6
0.947998
0.909912
1
0
0
no
null
null
no dnr
20
79
13.099609
104
20
38.5
null
3.799805
0.599976
0.599976
138
null
106
4
4,700
0
4
no(M2 and SIP pres)
4
619
0
79.69598
female
0
57
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
44
null
103,971.5
108,941
36.25
white
21.199219
44
0.571899
0.460999
9
0
0
no
0.75
0.7
no dnr
57
75
5.199219
75
18
38.29688
null
null
0.599976
1.299805
140
null
153
11
1,160
null
5
adl>=4 (>=5 if sur)
5
185
1
45.16397
female
1
14
MOSF w/Malig
ARF/MOSF
1
null
null
0
83,679
48,635.375
46,222
33.333313
black
28.5
37
0.44696
0.327942
13
0
0
metastatic
null
null
dnr after sadm
2
68
11.898438
65
10
39
300
null
null
1.099854
135
7.489258
205
21
2,765
null
null
<2 mo. follow-up
2.408203
14
1
56.03
male
0
19
MOSF w/Malig
ARF/MOSF
2
16
>$50k
0
34,500
20,821.2969
24,586
13
white
22.898438
17
0.711914
0.625
2
0
0
yes
0.6
0.4
no dnr
19
128
13.099609
65
11
38.09375
285.6875
2.799805
null
1.599854
136
7.439453
148
30
663
1
null
no(M2 and SIP pres)
1.166748
505
1
61.56598
female
1
339
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
44
1,016,214
null
null
42
white
34.296875
63
0.304993
0.192993
13
0
0
no
null
null
dnr after sadm
186
131
6
62
24
37.69531
366.625
3.799805
0.799927
0.599976
140
7.439453
137
7
2,000
null
null
adl>=4 (>=5 if sur)
2.867676
339
1
75.85498
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
0
6
$11-$25k
94
63,978
null
null
43
white
33.398438
66
0.112991
0.048996
1
0
0
no
0.3
0.2
dnr after sadm
6
73
11.898438
150
16
38.59375
61.66406
2.099609
null
0.899902
140
7.349609
113
18
3,500
null
1
<2 mo. follow-up
1
9
1
57.17999
female
0
5
CHF
COPD/CHF/Cirrhosis
3
17
under $11k
9
4,719
3,361.4668
3,103
6
white
17.097656
11
0.893921
0.821899
1
0
0
no
null
null
no dnr
5
98
23
115
12
36.69531
187.5
1.099854
3.299805
1.399902
144
7.40918
78
43
1,480
0
0
no(M2 and SIP pres)
0
617
0
68.68195
male
0
20
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
under $11k
37
68,006
41,975.4062
43,296
28.666656
white
27.199219
41
0.54895
0.434998
4
0
0
no
0.8
0.8
no dnr
20
57
10.298828
75
16
35
368
null
0.299988
0.5
135
7.459961
104
13
490
null
0
no(M2 and SIP pres)
0
616
0
38.56299
female
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
34,125
18,525.8594
15,510
47
null
95.59375
129
0
0
3
0
0
no
0.1
0.05
dnr after sadm
3
65
6.5
55
16
36.5
177.5
null
null
1.199951
137
7.459961
152
33
1,400
null
null
<2 mo. follow-up
1.051758
4
1
69.71899
male
0
5
Lung Cancer
Cancer
4
3
under $11k
0
4,335
null
null
8
white
22.699219
19
0.563965
0.241974
1
1
0
metastatic
null
null
no dnr
5
108
25.296875
70
12
36.29688
287.5
null
14.898438
7.399414
140
7.359375
77
83
1,975
null
0
null
0
68
1
58.793
male
0
11
CHF
COPD/CHF/Cirrhosis
5
10
$25-$50k
0
26,940
14,998.5781
15,549
30.5
white
26.199219
47
0.806885
0.687988
1
0
0
no
null
null
no dnr
11
55
16.296875
135
24
38
72.5
null
2.299805
1.5
137
7.319336
74
20
2,220
null
0
no(M2 and SIP pres)
0
616
0
75.93695
male
0
13
COPD
COPD/CHF/Cirrhosis
3
15
$11-$25k
0
13,997
9,179.1484
10,873
8
white
17.699219
37
0.751953
0.608887
1
0
0
metastatic
0.8
0.6
no dnr
13
100
4.699219
104
26
36
454.125
1.5
0.599976
5.699219
136
7.569336
165
35
675
2
4
adl>=4 (>=5 if sur)
4
143
1
64.85699
male
0
4
Colon Cancer
Cancer
2
null
null
0
10,381
6,016.0352
5,439
7
white
14.599609
5
0.846924
0.661987
1
1
0
metastatic
0.8
0.5
no dnr
4
73
10.5
65
32
38.59375
208.5625
2.899902
0.5
1.699951
135
7.389648
242
34
3,062
null
null
null
1.786621
536
1
62.41199
male
0
4
CHF
COPD/CHF/Cirrhosis
6
12
$11-$25k
0
3,217
2,380.4453
2,369
13
black
16.296875
11
0.900879
0.833984
1
1
0
no
0.6
0.5
no dnr
4
47
29.699219
125
42
38.79688
161.65625
null
0.399963
1.299805
146
7.389648
376
81
1,277
2
2
adl>=4 (>=5 if sur)
2
183
1
65.64294
male
1
36
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$25-$50k
44
205,473
118,190.562
110,383
48.25
white
34.195313
80
0.394958
0.27594
1
0
0
no
0.6
0.5
dnr after sadm
35
72
8.599609
60
12
35.69531
223.78125
null
1.5
1.899902
143
7.419922
121
38
2,365
null
0
<2 mo. follow-up
0
36
1
74.42297
female
0
112
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
under $11k
26
235,109
null
null
27.5
white
26.296875
34
0.61499
0.509888
2
0
0
no
0.8
0.7
no dnr
112
103
5.799805
84
20
36.09375
null
3.599609
1.299805
0.799927
146
null
88
14
2,710
null
0
adl>=4 (>=5 if sur)
0
174
1
50.63397
male
1
9
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
50,165
31,491.5781
30,715
55.5
black
43.695313
93
0.447998
0.328979
1
0
0
no
0.1
0.1
dnr after sadm
9
47
8.398438
60
32
36.59375
162.5
null
0.299988
0.799927
136
7.369141
128
28
1,690
null
0
<2 mo. follow-up
0
9
1
50.37399
female
0
9
Colon Cancer
Cancer
2
12
>$50k
0
9,406
6,254.0508
6,597
8
white
20
19
0.802979
0.580933
1
1
0
metastatic
0.8
0.6
no dnr
9
123
14.5
115
28
37.79688
366.625
null
null
1.099854
136
7.459961
259
25
3,820
1
0
no(M2 and SIP pres)
0
182
1
41.125
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
59,788
34,637.9688
41,609
29
white
27.5
28
0.823975
0.764893
2
0
0
no
0.85
0.8
no dnr
12
75
15.298828
115
28
38.19531
250
2.299805
4.399414
0.799927
146
7.449219
109
29
3,250
0
0
null
0
612
0
50.237
male
0
4
Lung Cancer
Cancer
1
16
>$50k
0
10,702
5,278.9219
3,583
14
white
16.699219
13
0.745972
0.483948
1
0
0
metastatic
0.9
0.6
no dnr
4
103
4.399414
80
20
36.29688
null
null
0.5
1
135
null
89
16
null
0
null
null
0.494751
199
1
65.67798
female
0
4
Lung Cancer
Cancer
1
null
null
0
10,072
5,396.9336
4,051
12
white
15.898438
17
0.727905
0.454956
1
0
0
metastatic
0.8
0.6
no dnr
4
95
10.898438
136
20
36.69531
348
null
0.699951
0.699951
138
7.439453
109
12
null
null
null
null
2.665527
432
1
78.64996
female
1
5
Coma
Coma
0
4
$11-$25k
100
15,947
9,404.7422
8,190
35
white
26.398438
58
0.059998
0.031998
1
0
0
no
null
null
dnr after sadm
3
105
7.799805
55
12
38.79688
202.5
null
0.599976
2.599609
133
7.459961
258
66
5,620
null
2
<2 mo. follow-up
2
5
1
54.33798
male
0
11
Cirrhosis
COPD/CHF/Cirrhosis
2
6
under $11k
0
14,277
9,446.7812
9,115
16
black
24.199219
31
0.756958
0.61499
1
0
0
no
0.75
0.5
no dnr
11
79
12.099609
49
24
36.5
597.125
null
0.299988
1
139
7.319336
189
31
null
4
3
no(M2 and SIP pres)
3
141
1
45.37997
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
0
35,444
22,814.7031
23,440
26.666656
other
24.597656
45
0.85791
0.807983
1
1
0
no
0.85
0.7
no dnr
21
49
7.5
62
28
35.29688
null
3.599609
1.299805
1.699951
130
null
76
43
2,900
6
4
null
4
97
1
58.34598
male
1
17
MOSF w/Malig
ARF/MOSF
1
12
$11-$25k
100
33,035
20,674.2188
20,585
27.666656
white
43.796875
96
0.001
0
1
0
0
yes
0.25
0.15
dnr after sadm
1
107
8.599609
74
16
35.39844
null
null
0.5
1.899902
145
null
212
29
2,350
null
1
<2 mo. follow-up
1
17
1
52.86499
female
1
11
MOSF w/Malig
ARF/MOSF
1
null
null
100
32,148
19,020.4219
18,085
19
black
22.699219
38
0.131989
0.060997
6
0
0
metastatic
0.1
0
dnr before sadm
-3
138
28.5
145
10
38.79688
236
2.099609
15.199219
1
140
7.439453
136
30
3,540
null
null
<2 mo. follow-up
4.486328
11
1
70.85596
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
11
null
0
29,607
19,447.8281
20,150
10.333328
white
26.398438
38
0.688965
0.596924
1
0
0
yes
0.9
0.8
no dnr
14
60
11.898438
65
30
38
272
4
0.399963
0.599976
124
7.40918
108
10
3,800
2
3
SIP>=30
3
610
0
72.422
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
26,938
15,409.5234
16,714
16
white
21.097656
38
0.792969
0.724976
4
0
0
no
0.9
0.85
no dnr
6
65
11.5
140
16
39.09375
292
1.799805
1.099854
1.799805
137
7.259766
121
14
2,850
null
0
no(M2 and SIP pres)
0
540
1
70.36298
male
1
14
COPD
COPD/CHF/Cirrhosis
2
16
null
0
50,172
29,052.5781
27,719
31.333328
white
18.5
36
0.820923
0.708984
1
0
0
yes
0.5
0.4
dnr after sadm
12
65
6.5
55
20
36.09375
276.1875
3.899902
0.799927
1.199951
138
7.439453
83
21
2,075
null
0
<2 mo. follow-up
0
14
1
65.43195
male
0
5
Lung Cancer
Cancer
2
15
>$50k
0
11,205
5,668.1016
3,621
13
white
10.798828
21
0.810913
0.593994
1
1
0
metastatic
null
null
no dnr
5
65
14
135
6
38.5
185
null
0.299988
0.899902
142
7.449219
92
7
3,515
0
0
no(M2 and SIP pres)
0
181
1
78.47998
female
1
13
COPD
COPD/CHF/Cirrhosis
2
12
null
9
36,049
21,361.4844
20,538
32
white
25.199219
36
0.668945
0.496948
1
0
0
no
0.7
0.6
dnr after sadm
10
99
10.699219
75
22
38.09375
228.5625
3
0.399963
0.799927
142
7.479492
117
5
null
null
6
<2 mo. follow-up
6
13
1
77.12
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
$25-$50k
9
49,281
29,451.9375
32,611
23.333328
white
38.898438
52
0.291992
0.181976
4
0
0
no
0.5
0.35
no dnr
18
107
10
109
28
36.59375
176.1875
4
0.299988
0.899902
139
7.379883
132
15
1,600
1
1
no(M2 and SIP pres)
1
83
1
57.92999
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
under $11k
0
43,351
25,587.25
27,790
21.666656
white
24.5
40
0.780884
0.708984
1
1
0
yes
0.8
0.75
no dnr
14
73
8.199219
75
0
38.09375
200
null
null
0.899902
141
7.449219
109
16
3,225
1
1
SIP>=30
1
572
1
44.76898
female
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
>$50k
9
41,805
23,602.1875
21,833
37
white
28.597656
39
0.787964
0.718994
1
0
0
no
0.8
0.8
no dnr
12
74
0.699951
100
32
36.59375
204.0625
null
null
0.799927
136
7.359375
205
21
4,485
null
0
no(M2 and SIP pres)
0
608
0
58.793
male
0
81
ARF/MOSF w/Sepsis
ARF/MOSF
0
5
null
0
264,071
151,383.5
151,790
21.75
other
20.398438
32
0.813965
0.751953
33
0
0
no
null
null
no dnr
81
98
0.099991
105
20
38.5
null
3.199707
0.699951
0.699951
140
null
99
6
4,625
null
1
adl>=4 (>=5 if sur)
1
608
0
52.42999
male
0
28
Cirrhosis
COPD/CHF/Cirrhosis
3
13
>$50k
0
102,454
null
null
29.5
white
29.597656
55
0.665894
0.491943
1
1
0
no
0.5
0.4
no dnr
28
58
19.398438
115
8
40
142
2
0.299988
0.799927
143
7.399414
119
39
1,340
null
0
no(M2 and SIP pres)
0
608
0
70.612
male
0
22
Coma
Coma
0
10
null
61
48,467
28,802.6406
31,511
24
black
20.699219
34
0.445984
0.372986
1
0
0
no
0.1
0.05
no dnr
22
79
11.199219
130
25
36.19531
null
4.199219
1.199951
1.399902
141
null
96
21
2,275
null
0
adl>=4 (>=5 if sur)
0
608
0
69.771
female
0
9
Colon Cancer
Cancer
1
13
$25-$50k
0
13,072
7,609.6094
6,418
14
white
14.699219
12
0.838989
0.645996
1
0
0
metastatic
0.5
0.2
no dnr
9
105
6.199219
130
30
36.39844
53
2
3.899902
0.599976
138
7.339844
305
25
239
0
0
<2 mo. follow-up
0
37
1
69.08698
female
1
39
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
null
0
180,614
102,454.125
100,007
31
white
23.199219
26
0.761963
0.68689
6
0
0
no
0.8
0.75
dnr after sadm
17
112
13
135
24
37
93.75
null
1.599854
0.699951
140
7.389648
185
16
4,860
null
6
<2 mo. follow-up
6
39
1
76.54797
male
1
26
MOSF w/Malig
ARF/MOSF
0
4
under $11k
26
99,145
57,523.125
58,555
24.5
white
25.5
25
0.422974
0.302979
14
0
0
yes
0.8
0.7
dnr after sadm
6
102
6.099609
55
24
36.09375
null
null
3.199707
0.799927
135
null
331
11
null
null
7
<2 mo. follow-up
7
26
1
61.45697
female
0
13
Colon Cancer
Cancer
1
12
null
0
31,807
19,082.6562
17,561
24.5
white
14.699219
10
0.851929
0.671997
1
0
0
metastatic
0.85
0.65
no dnr
13
105
6.5
110
22
36.59375
200
null
0.299988
0.599976
141
7.289062
122
5
null
0
0
no(M2 and SIP pres)
0
524
1
43.159
male
0
68
CHF
COPD/CHF/Cirrhosis
3
15
$11-$25k
0
181,664
113,593.125
120,379
13.75
black
21.597656
25
0.900879
0.833984
1
0
0
no
null
null
no dnr
68
110
16.5
112
32
36.39844
null
3.299805
0.199982
0.699951
141
null
285
32
2,800
0
0
no(M2 and SIP pres)
0
607
0
74.83899
female
0
7
COPD
COPD/CHF/Cirrhosis
1
14
under $11k
0
13,540
8,456.5469
7,916
9
white
19.699219
21
0.819946
0.706909
1
0
0
no
0.8
0.5
no dnr
7
68
14.298828
125
42
39
124.48438
2.799805
0.699951
0.899902
138
7.429688
106
29
1,525
1
1
SIP>=30
1
606
0
59.504
male
1
15
MOSF w/Malig
ARF/MOSF
3
12
$11-$25k
44
72,035
43,440.6875
39,870
29.666656
white
34.09375
88
0.071991
0.025997
16
1
0
metastatic
0.5
0.5
dnr after sadm
2
0
10.5
0
0
36
234.28125
null
0.399963
0.799927
143
7.399414
133
17
1,070
null
3
<2 mo. follow-up
3
15
1
81.31995
male
0
4
Lung Cancer
Cancer
2
12
$25-$50k
0
6,434
3,885.0566
2,558
20
white
26.898438
10
0.405945
0.106995
1
0
0
metastatic
0.8
0.4
no dnr
4
72
10.798828
85
7
38.59375
146.65625
null
null
1.099854
136
7.479492
141
48
1,590
1
0
null
0
289
1
40.68698
male
0
6
CHF
COPD/CHF/Cirrhosis
2
9
$11-$25k
0
8,484
5,322.5312
4,837
19
black
14.199219
11
0.946899
0.909912
1
0
0
no
null
null
no dnr
6
105
30.5
115
32
35.59375
66
2
null
5.599609
137
7.239258
259
72
485
0
null
no(M2 and SIP pres)
0.494751
605
0
58.23999
female
0
26
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
>$50k
0
99,840
56,244.9062
52,594
33.75
white
30.796875
40
0.721924
0.635986
1
0
0
no
0.8
0.512
no dnr
26
58
2.5
125
36
40
208.5625
null
1.099854
1.299805
150
7.399414
141
27
2,890
null
0
no(M2 and SIP pres)
0
605
0
70.97894
male
0
6
CHF
COPD/CHF/Cirrhosis
3
0
under $11k
0
4,417
3,228.3809
3,390
12
black
19.898438
24
0.844971
0.744995
1
0
0
no
null
null
no dnr
6
96
10
72
16
36.79688
225.90625
null
0.699951
0.699951
139
7.389648
100
5
null
0
0
no(M2 and SIP pres)
0
605
0
82.54895
female
1
9
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
9
12,084
7,861.2812
8,216
12
white
26.199219
40
0.526978
0.326965
1
0
0
yes
0.05
0.05
dnr after sadm
2
102
7.699219
125
40
37.79688
328.5625
null
null
0.699951
137
7.369141
228
26
1,770
0
0
<2 mo. follow-up
0
9
1
64.80194
female
0
24
MOSF w/Malig
ARF/MOSF
2
15
null
0
106,845
64,932.3125
61,270
13.333328
white
28.398438
63
0.474976
0.355957
34
0
0
yes
0.7
0.6
no dnr
24
65
15.199219
125
14
39.5
132.5
2
2.099609
1.299805
136
7.389648
81
12
1,750
1
3
adl>=4 (>=5 if sur)
3
560
1
70.07794
male
0
4
COPD
COPD/CHF/Cirrhosis
2
8
null
9
null
2,366.9219
2,386
9
white
21.097656
32
0.805908
0.685913
1
0
0
no
0.7
0.7
no dnr
4
100
1.299805
104
22
38.39844
364
null
0.5
0.899902
137
7.399414
101
10
1,775
null
7
null
7
83
1
72.12
male
1
31
MOSF w/Malig
ARF/MOSF
1
7
$25-$50k
0
172,847
98,894.1875
95,441
42
black
36.398438
69
0.213989
0.117996
4
0
0
metastatic
0.3
0.3
dnr after sadm
23
113
26.5
115
9
36.5
275
null
2.699707
6.5
125
7.399414
354
108
533
0
0
<2 mo. follow-up
0
31
1
59.00598
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
14
>$50k
37
51,587
31,702.0469
29,248
42.5
other
37.695313
69
0.344971
0.228973
2
1
0
no
0.8
0.75
no dnr
11
58
10.398438
75
16
35.09375
123.32812
2.099609
0.599976
5
133
7.419922
216
98
625
null
6
null
6
413
1
72.65997
female
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
1
2
under $11k
100
24,193
16,319.5625
14,451
46
white
78.390625
70
0
0
2
0
0
no
0.05
0
dnr after sadm
2
96
6.399414
97
20
36.59375
476.1875
3.299805
0.899902
0.899902
137
7.5
93
10
900
null
null
<2 mo. follow-up
1.823486
3
1
63.48798
female
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
null
0
55,969
32,768.0938
31,940
36
black
41.195313
104
0.334961
0.219971
8
0
0
no
0.1
0.5
dnr after sadm
5
130
7.299805
130
30
39.79688
296.625
null
null
1.899902
130
7.399414
206
26
2,555
null
5
<2 mo. follow-up
5
7
1
55.50699
male
0
3
CHF
COPD/CHF/Cirrhosis
3
18
null
0
3,751
2,599.6055
2,144
6
white
18.597656
20
0.897949
0.828979
1
0
0
no
0.85
0.8
no dnr
3
0
21.097656
0
0
36.29688
53.32812
1.299805
17.597656
3.699707
147
7.289062
7
11
0
0
null
no(M2 and SIP pres)
0.494751
599
0
60.82999
male
0
38
ARF/MOSF w/Sepsis
ARF/MOSF
0
7
$25-$50k
44
null
55,461.4062
61,053
24.5
white
24.796875
41
0.625
0.520996
4
0
0
no
0.9
0.9
no dnr
38
76
5.099609
88
28
36.79688
null
null
1.5
0.599976
127
null
184
9
null
null
0
adl>=4 (>=5 if sur)
0
599
0
79.65796
female
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
0
115,444
62,643.2812
67,554
46
white
49.59375
84
0.048996
0.014999
10
0
0
no
0.3
0.2
dnr after sadm
4
108
7.399414
125
0
38.5
183.65625
3.899902
2.699707
1.799805
140
7.5
199
22
3,850
null
0
<2 mo. follow-up
0
4
1
33.75198
female
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
$25-$50k
0
176,006
96,187.125
99,543
34.333313
white
28.5
85
0.779907
0.707886
49
1
0
no
0.9
0.85
no dnr
21
72
7.699219
115
20
37.79688
233.3125
null
null
0.899902
144
7.339844
133
24
null
null
6
<2 mo. follow-up
6
47
1
68.07397
male
0
27
Cirrhosis
COPD/CHF/Cirrhosis
3
20
>$50k
0
83,878
52,124.8438
55,554
21.5
white
31.5
56
0.18399
0.051994
15
0
0
metastatic
0.5
0.15
dnr after sadm
6
82
4.5
60
24
36.59375
null
null
0.399963
1
140
null
98
12
null
null
null
<2 mo. follow-up
3.181641
36
1
48.33698
male
0
4
Lung Cancer
Cancer
2
13
null
0
7,371
4,496.9922
2,540
17
black
7.699219
12
0.870972
0.710938
1
0
0
metastatic
0.8
0.6
no dnr
4
73
11.798828
75
22
36.19531
390.4375
null
0.399963
1.299805
136
7.479492
66
19
2,000
null
null
SIP>=30
1.844482
597
0
66.784
male
0
4
Lung Cancer
Cancer
3
13
>$50k
0
6,887
3,874.1602
1,958
13
white
11.898438
14
0.791992
0.56189
1
1
0
metastatic
null
null
no dnr
4
65
10.798828
125
29
36.29688
114.28125
1.699951
0.299988
9.099609
133
7.389648
108
66
220
null
null
SIP>=30
2.168945
155
1
47.702
male
0
7
Cirrhosis
COPD/CHF/Cirrhosis
3
4
under $11k
0
5,262
3,858.5606
3,823
2.5
white
15.5
24
0.893921
0.821899
1
1
0
no
0.9
0.85
no dnr
7
125
22.5
115
36
38
190
null
2.5
0.699951
142
7.389648
107
19
3,215
2
null
adl>=4 (>=5 if sur)
1.838867
543
1
68.80499
male
0
5
Lung Cancer
Cancer
3
12
$11-$25k
0
7,790
4,193.7852
2,616
14
white
12
9
0.786987
0.552979
1
1
0
metastatic
1
0.9
no dnr
5
65
22.898438
115
35
35.79688
47
2.199707
2.099609
4.899414
146
7.179688
224
114
224
null
null
no(M2 and SIP pres)
2.179688
595
0
75.31799
male
0
18
CHF
COPD/CHF/Cirrhosis
4
null
null
0
13,355
9,905.4141
10,761
8.666664
white
22.699219
30
0.791992
0.665894
1
1
0
no
null
null
dnr after sadm
10
75
10.5
100
22
36
null
null
0.899902
0.799927
134
null
330
17
3,300
null
null
<2 mo. follow-up
3.402832
19
1
72.96594
male
0
17
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
0
117,270
66,003.5625
58,856
19.333328
hispanic
27.898438
43
0.593994
0.402954
27
0
0
no
null
null
no dnr
17
127
11.5
125
10
38.69531
118.32812
null
null
1.099854
134
7.429688
168
16
2,495
2
0
no(M2 and SIP pres)
0
236
1
73.37396
male
1
4
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
under $11k
0
11,001
7,667.4492
8,798
14
white
28.199219
30
0.702881
0.612915
1
1
0
no
null
null
no dnr
4
77
5.099609
80
20
35.89844
null
null
null
0.699951
137
null
93
6
3,200
1
null
<2 mo. follow-up
1.166748
4
1
71.58698
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
9
36,480
22,031.25
20,923
20.5
black
25.597656
44
0.697998
0.60791
3
0
0
no
null
null
no dnr
12
69
5.399414
50
16
37.69531
null
null
0.5
0.799927
138
null
75
6
1,400
null
6
null
6
78
1
58.06198
male
0
3
CHF
COPD/CHF/Cirrhosis
3
11
$11-$25k
0
null
null
null
9
black
23.5
17
0.843994
0.743896
1
0
0
no
0.85
0.8
no dnr
3
138
11.699219
145
0
38.19531
190
null
0.599976
0.699951
143
7.459961
101
14
1,680
0
0
null
0
592
0
61.32199
male
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
81,430
45,189.9688
42,309
47
black
34.796875
55
0.537964
0.42395
8
1
0
no
0.4
0.3
dnr after sadm
5
67
6.299805
119
28
38.89844
null
2.5
5.599609
0.799927
137
null
80
5
null
null
null
<2 mo. follow-up
2.124512
5
1
26.355
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
null
41,310.8438
40,802
9.25
white
16.699219
28
0.929932
0.903931
8
0
0
no
1
1
no dnr
27
75
11.5
78
14
36.5
328
3.099609
0.5
5.5
130
7.349609
404
31
20
0
0
no(M2 and SIP pres)
0
591
0
63.30499
female
0
12
COPD
COPD/CHF/Cirrhosis
2
10
under $11k
0
50,617
27,886.4531
35,712
35.5
white
23.199219
28
0.816895
0.702881
3
0
0
no
0.8
0.75
no dnr
12
50
5.799805
165
28
36.39844
116.65625
2
null
3.5
133
7.299805
322
74
45
0
5
no(M2 and SIP pres)
5
590
0
58.056
female
1
7
Lung Cancer
Cancer
1
12
$25-$50k
9
6,012
3,815.5801
3,552
8
white
14.5
23
0.73999
0.474976
1
0
0
metastatic
0.2
0.05
dnr after sadm
2
157
12.898438
135
32
38.09375
null
null
null
0.699951
141
null
498
4
1,405
null
3
<2 mo. follow-up
3
7
1
34.54898
female
1
4
Coma
Coma
0
null
under $11k
100
21,703
13,767.3281
12,530
36
other
51.898438
58
0.002
0
1
0
0
no
0.4
0.35
dnr after sadm
4
117
10.398438
105
28
36.39844
138.75
null
0.5
1.399902
136
7.459961
142
36
3,280
null
0
<2 mo. follow-up
0
4
1
69.74097
female
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
$11-$25k
89
24,106
14,195.3359
13,228
24
black
37.195313
65
0.085999
0.032997
1
0
0
no
0.3
0.2
dnr after sadm
8
112
25.796875
80
14
36.5
200
null
null
1.899902
141
7.30957
196
32
2,210
null
7
<2 mo. follow-up
7
8
1
68.10394
male
0
5
Lung Cancer
Cancer
1
12
null
0
10,815
5,907.2461
4,377
13
white
13.699219
5
0.761963
0.509888
1
0
0
metastatic
0.8
0.6
no dnr
5
122
8.5
105
25
37.59375
220
2.799805
0.399963
1.299805
136
7.299805
187
27
1,330
0
null
no(M2 and SIP pres)
0.494751
273
1
62.51099
female
0
5
Lung Cancer
Cancer
2
12
$25-$50k
0
12,801
6,578.5117
4,481
11
white
12.298828
12
0.793945
0.564941
1
0
0
metastatic
0.8
0.6
no dnr
5
72
3.899902
68
20
35.79688
null
4
0.599976
0.799927
138
null
191
23
4,475
0
0
no(M2 and SIP pres)
0
590
0
45.32498
female
0
25
Coma
Coma
1
null
under $11k
61
55,698
null
null
22.5
black
22.796875
20
0.625977
0.563965
1
0
0
no
0.8
0.78
no dnr
25
65
7.099609
128
32
36.79688
238.09375
2.799805
0.299988
0.699951
139
7.449219
223
16
1,520
null
0
null
0
512
1
62.38199
male
0
13
Cirrhosis
COPD/CHF/Cirrhosis
4
12
$11-$25k
9
26,571
18,846.5781
18,957
19.5
white
24.199219
31
0.668945
0.495972
1
0
0
no
0.6
0.4
no dnr
13
38
15.298828
150
24
35.69531
null
null
null
0.799927
135
null
111
28
915
0
null
<2 mo. follow-up
0.494751
44
1
41.93799
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
4
null
null
0
25,122
15,689.3438
16,556
25
white
59.695313
68
0.068985
0.023998
2
0
0
no
null
null
dnr after sadm
2
62
17.296875
125
26
38
362
null
0.299988
2
136
7.439453
286
35
3,140
null
null
<2 mo. follow-up
2.249512
3
1
38.91599
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
under $11k
9
15,182
10,071.1641
10,648
14.5
black
23
28
0.873901
0.828979
1
0
0
no
null
null
no dnr
10
115
31.296875
145
31
36.59375
246.65625
2.5
0.899902
0.399963
131
7.40918
89
5
6,820
6
5
adl>=4 (>=5 if sur)
5
395
1
26.883
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
9
51,208
29,285.9688
31,848
16.666656
black
26
24
0.861938
0.813965
2
0
0
no
0.99
0.99
no dnr
16
95
30.199219
145
24
38.5
236
2.399902
0.699951
1.299805
137
7.399414
94
8
2,250
null
0
no(M2 and SIP pres)
0
588
0
64.59698
female
0
47
ARF/MOSF w/Sepsis
ARF/MOSF
1
5
$11-$25k
41
150,749
84,257.9375
97,802
33.25
white
16.398438
34
0.776978
0.704956
5
0
0
no
0.5
0.35
dnr after sadm
13
119
13.199219
130
6
35.59375
340
2.299805
5.5
0.899902
137
7.469727
324
38
1,335
null
1
null
1
588
0
57.547
male
0
11
Colon Cancer
Cancer
1
16
>$50k
0
24,415
13,932.5469
11,493
7.5
white
12.898438
14
0.875977
0.718994
1
0
0
metastatic
1
0.8
no dnr
11
108
11.5
125
30
38
250
null
null
0.899902
142
7.449219
148
28
1,175
0
0
no(M2 and SIP pres)
0
588
0
57.74899
male
1
9
Lung Cancer
Cancer
1
14
>$50k
0
9,471
5,769.2539
6,352
12
white
27.5
22
0.468994
0.152985
1
0
0
metastatic
0.4
0.1
dnr after sadm
4
109
8.5
84
16
36.79688
null
null
0.399963
0.799927
134
null
69
6
4,300
null
1
<2 mo. follow-up
1
9
1